• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Adapt Pharma

Surgeon general issues rare advisory urging public to carry overdose reversal drug

April 5, 2018 By Sarah Faulkner

Narcan nasal spray

For the first time in 13 years, the U.S. surgeon general has issued a public health advisory. The last notice, composed in 2005, centered around the risks of drinking during pregnancy. The one issued by surgeon general Jerome Adams today urges the public to carry naloxone, an opioid overdose reversal drug. “Naloxone is a safe antidote […]

Filed Under: Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals Tagged With: Adapt Pharma

Trump touts Adapt Pharma’s plan to distribute free opioid-overdose devices to schools

March 20, 2018 By Sarah Faulkner

Adapt Pharma

In a wide-ranging speech yesterday detailing his administration’s plan to tackle the opioid crisis in the U.S., President Trump touted Adapt Pharma‘s move to distribute free doses of its overdose-reversal nasal spray, Narcan, to schools and universities. As part of an initiative launched in collaboration with The Clinton Foundation last year, Adapt previously offered 20,000 […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Adapt Pharma

The company behind Narcan looks toward a treatment for fentanyl overdoses

March 13, 2018 By Sarah Faulkner

Opiant Pharmaceuticals

Despite growing attention from lawmakers and doctors, the opioid crisis is not slowing up in the U.S. A new report published last week by the Centers for Disease Control and Prevention showed that emergency room visits for opioid overdoses jumped 30% in 45 states from 2016 to 2017. The problem has morphed over the years […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: Adapt Pharma, Centers for Disease Control & Prevention, opiantpharmaceuticals

Adapt Pharma touts usability data for Narcan nasal spray

June 13, 2017 By Sarah Faulkner

Adapt Pharma

Adapt Pharma touted data today from 2 human factors studies that evaluated the usability of its Narcan nasal spray by adolescents and people with low literacy. The Dublin-based company’s product is a ready-to-use, needle-free device that delivers a single dose of naloxone in a nasal spray to someone experiencing an opioid overdose and does not require […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory Tagged With: Adapt Pharma

Adapt Pharma seeks regulatory nod for naloxone nasal spray in Europe

February 21, 2017 By Sarah Faulkner

Adapt Pharma

Adapt Pharma said today that it filed a European Marketing Application for its naloxone hydrochloride nasal spray for the treatment of opioid overdose. The Dublin-based company’s product is a ready-to-use, needle-free device that delivers a single dose of naloxone in an 0.1 mL nasal spray and does not require assembly prior to use, according to […]

Filed Under: Featured, Pain Management, Regulatory/Compliance, Wall Street Beat Tagged With: Adapt Pharma

FDA approves 2mg Narcan nasal spray for opioid overdose treatment

January 25, 2017 By Sarah Faulkner

Adapt Pharma said today that the FDA approved the 2mg formulation of its Narcan nasal spray for the emergency treatment of opioid overdose. The 2mg dose is intended for opioid-dependent patients that are at risk for severe withdrawal, but are not at a high risk for continued opioid exposure. The approval comes 1 year after […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: Adapt Pharma

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS